SPONSOR
Hunan Province Tumor Hospital
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Non-small Cell Lung CancerNon Small Cell Lung CancerEGFR Gene MutationALK Gene MutationROS1 Gene MutationMET Gene Mutation
NCT05014464 Phase 2
Recruiting
ALK Tyrosine Kinase Inhibitors in ALK-rearranged Advanced Squamous Cell Carcinoma
Non-small Cell Lung Cancer
NCT04322578 Phase 2
Recruiting
Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping Advanced NSCLC
Non-small Cell Lung Cancer
NCT04322890 Phase 2
Recruiting
Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation
Non Small Cell Lung Cancer